Oncology/tumor: Phase II trials

A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma (STERIMGLI)

Durvalumab,

Phase II

glioblastoma, hypofractionated stereotactic radiation therapy

France

Ongoing, not yet recruiting

https://clinicaltrials.gov/ct2/show/NCT02866747?term=brain+tumour&rcv_s=07%2F25%2F2016&rcv_e=08%2F25%2F2016&lup_s=07%2F25%2F2016&lup_e=08%2F25%2F2016&rank=11


Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Intra-arterial Cetuximab and Mannitol

Phase II

Brain cancer

United States

Recruiting

https://clinicaltrials.gov/ct2/show/NCT02861898?term=brain+tumour&rcv_s=07%2F25%2F2016&rcv_e=08%2F25%2F2016&lup_s=07%2F25%2F2016&lup_e=08%2F25%2F2016&rank=2


Phase II Study of Proton Radiation Therapy for Neuroblastoma

Proton Beam Radiation Therapy

Phase II

United States

Recruiting

Click here for further information


More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

5-ALA (Gliolan)

Phase II

United States

Recruiting

Click here for further information


Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors

Lapatinib

Phase II

Greece

Completed

Click here for further information